Home
/ JanOne
/ Competitors

JanOne Competitors and Similar CompaniesClear all

Assertio's competitors and similar companies include Alembic Pharmaceuticals and UCB.

	Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1995	Founding Date 2010	Founding Date 1928
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Lake Forest, US HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 3058% increase	Employees 14,858	Employees 9,052
Valuation ($)	Valuation ($) 104.9 m	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) $118.7m (FY, 2025)	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)
Net income	Net income ($30.4m) (FY, 2025)	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)
Operating ⚠
Products	Products 8 (FY, 2020)	Products 145 (FY, 2024)	Products N/A